Newsday, the premier news publication on Long Island, reports on a local educational event that highlighted the latest in pancreatic cancer treatment advances and approaches, clinical trials, genetics, early detection, and research.

A panel discussion was led by prominent experts from NYU Langone’s Perlmutter Cancer Center: Francis Arena, MD, medical director of Perlmutter Cancer Center at NYU Langone Arena Oncology, and Diane M. Simeone, MD, director of the Pancreatic Cancer Center and associate director of translational research.

Pancreatic cancer, the third leading cause of cancer-related deaths in the United States, also has the lowest 5-year survival rate of all cancers—9 percent. However, Dr. Arena says that there are new treatment options and improved imaging technologies that are advancing patient outcomes.

“If someone says there is nothing we can do, if you hear that—what should you do? Run. Run as fast as you can,” urges Dr. Arena, underscoring hope for patients and their families.

Read more from Newsday (subscription required).